Hancock: Life should return to normal by spring thanks to Oxford vaccine approval


As a race begins again time to get as many people as possible vaccinated with the Oxford / AstraZeneca vaccine, formal approval obtained this morning, Life could now return to normal by spring, Matt Hancock has suggested.

The Minister of Health for England said vaccinations will begin on Monday, concentrating on providing as many people as possible with the first dose, which provides some protection, to minimize hospitalizations. 100 million doses of the vaccine have been requested by the British government, enough to inoculate 50 million people.

Hancock, who welcomed the approval of the new vaccine as “fantastic news,” by the Medicines and Healthcare products Regulatory Agency, said he is now “very confident that we will have overcome the problem by spring.”

“We also know there is a way out of the situation. The vaccine provides that way out. We just have to keep our nerve in the coming weeks.”We also know that there is a way out of the situation. The vaccine provides that way out. In the coming weeks, we just have to keep our nerve.

In the House of Commons this afternoon, the Minister is expected to declare that more regions of England will step up to the highest level of level 4.

As it is cheaper and easier to administer than the Pfizer vaccine, which must be stored at minus 70 degrees, the new vaccine has been described as a’ game-changer.’

The announcement came just a couple of hours after the U.K. Within 28 days of a positive test, 53,135 new Covid cases were registered, the largest single-day rise since mass testing started, and 414 more deaths.

Boris Johnson tweeted in reaction to the approval of the new vaccine, “It’s really fantastic news – and a triumph for UK science – that the @UniofOxford/@AstraZeneca vaccine has been approved for use. We will now be vaccinating as many people as possible as soon as possible.”

“Much needed good news on the covid front – and it’s very good news. We still have some difficult winter weeks ahead – but the light at the end of the tunnel just got a lot brighter. Let’s keep at it now – spring will bring better times.”Good news on the covid front is much needed – and it’s very good news. We still have some challenging winter weeks ahead of us, but the light just got a lot brighter at the end of the tunnel. Let’s keep it now – spring will bring better times.

The Scottish Minister, Alister Jack, also hailed the approval of the vaccine as’ utterly wonderful news.’

He added: “Every additional vaccine that becomes available brings us one step closer to returning as soon as possible to our normal lives.”

“As with the Pfizer/BioNTech vaccine, the UK government has sourced and paid for millions of doses of the Oxford/AstraZeneca vaccine for people in all parts of the UK.”

Professor Chris Whitty, Chief Medical Officer of England, emphasized that the vaccine was “safe and effective,” adding, “It’s very good news that the independent regulator has now approved Oxford/vaccine AstraZeneca’s for use.”

The Joint Committee on Vaccination and Immunization, which advises ministers, will issue its most recent recommendations on who, and in what order, should receive the vaccine.

Data reported in the medical journal The Lancet in early December showed that in a sample of 4,440 people who received two regular doses of the vaccine, the vaccine was 62 percent successful in preventing covid-19, compared with 4,455 people who received placebo.

There was 90 percent safety against Covid-19 in 1,367 people who received a half first dose of the vaccine followed by a full second dose, compared to a control group of 1,374 people.

The MHRA approved the administration of individuals with two full doses of the vaccine.

In the vaccine trial, 10 people were hospitalized with coronavirus, including 2 with extreme covid, who received placebo dummy preparation, resulting in one death.

However, among individuals who obtained the vaccine, there were no hospitalizations or serious cases.

People receiving the Oxford or Pfizer/BioNTech vaccine, which is also being phased out, are now receiving their first dose of the vaccine, followed up to 12 weeks later by a second dose.

The aim is to send your first dose of the Covid 19 vaccine to as many individuals as possible.

“This is important because it means we can give more people the first dose faster and they get the protection that the first dose provides,” Mr. Hancock said.

The researchers and regulators have looked at the data and found that you will get a first dose.


Leave A Reply